✦ LIBER ✦

Palliative therapy of advanced hepatocellular carcinoma - doxorubicin and tamoxifen vs. tamoxifen

✍ Scribed by G. Schachschal; H. Lochs; M. Plauth

Book ID: 118568655
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 167 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80888-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of doxorubicin and tamoxifen

Comparison of doxorubicin and tamoxifen vs. tamoxifen in the treatment of advanced hepatocellular carcinoma

✍ Schachschal, G.; Lochs, H.; Plauth, M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Tamoxifen vs. tamoxifen-thalidomide for

Tamoxifen vs. tamoxifen-thalidomide for advanced hepatocellular carcinoma

✍ MONDRAGONSANCHEZ, R; GOMEZGOMEZ, E; MARTINEZGONZALEZ, N; MONDRAGONSANCHEZ, A; BE 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 44 KB

Tamoxifen and medroxyprogesterone therap

Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma

✍ Rendina, G.M.; Donadio, C.; Fabri, M.; Mazzoni, P.; Nazzicone, P. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Controlled trial of tamoxifen in patient

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

✍ Francisco J. Martínez Cerezo; Alberto Tomás; Luis Donoso; Jaime Enríquez; Carlos 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 410 KB

279 Tamoxifen and medroxyprogesterone th

279 Tamoxifen and medroxyprogesterone therapy for advanced endonetrial carcinoma

✍ G.M. Rendina; C. Donadio; H. Fabri; P. Narricone; P. Mazzoni 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Use of tamoxifen in advanced-stage hepat

Use of tamoxifen in advanced-stage hepatocellular carcinoma : A systematic review

✍ Anna K. Nowak; Martin R. Stockler; Pierce K. H. Chow; Michael Findlay 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## BACKGROUND Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide. Survival is poor for patients with advanced‐stage HCC, and small trials of tamoxifen for patients with this disease have shown conflicting results. The authors conducted a systema